Clinuvel Pharmaceuticals Market Cap

Clinuvel Pharmaceuticals has a market cap or net worth of 502.01 million as of March 9, 2026. Its market cap has decreased by -8.38% in one year.

Market Cap

502.01M

Enterprise Value

269.33M

Revenue

96.30M

Ranking

n/a

PE Ratio

15.54

Stock Price

10.00

Market Cap Chart

Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 502.01M, an increase of 9,506.57%. That is a compound annual growth rate of 19.96%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	502.01M	-19.74%
Dec 31, 2025	625.50M	3.84%
Dec 31, 2024	602.36M	-24.90%
Dec 29, 2023	802.04M	-25.09%
Dec 30, 2022	1.07B	-20.36%
Dec 31, 2021	1.34B	21.91%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Racura Oncology	447.04M
Immutep	582.12M
Opthea	738.77M
Dimerix	243.16M
Orthocell	240.11M
Tetratherix	196.97M
Clarity Pharmaceuticals	1.33B
PYC Therapeutics	1.46B

Market Cap Rankings